Provided by Tiger Fintech (Singapore) Pte. Ltd.

HBM HOLDINGS-B

6.700
+0.72012.04%
Volume:16.07M
Turnover:103.44M
Market Cap:5.07B
PE:27.75
High:6.860
Open:6.000
Low:6.000
Close:5.980
Loading ...

Hong Kong Stocks Surge on Arisen Expectations for Forceful Stimulus; Peijia Medical, HBM Surge Over 12%

MT Newswires Live
·
1 hour ago

HBM Holdings Receives Upfront Payment, Stake for Immunological Diseases Antibody

MT Newswires Live
·
3 hours ago

BUZZ-HK-listed Hbm at 3-year peak on getting paid for license deal

Reuters
·
6 hours ago

BRIEF-HBM Holdings Says Upfront Payment Received Under License Agreement With Windward Bio AG

Reuters
·
9 hours ago

Hbm Holdings - Upfront Payment Received Under License Agreement With Windward Bio Ag for Hbm9378/Skb378

THOMSON REUTERS
·
10 hours ago

HBM Joint Venture Strikes Licensing Deal to Advance Novel CRH Therapies

MT Newswires Live
·
26 Feb

HBM Holdings Limited (HKG:2142) Stock Catapults 78% Though Its Price And Business Still Lag The Industry

Simply Wall St.
·
21 Feb

HBM Holdings Sees Up to 22 Million Yuan Profit in 2024

MT Newswires Live
·
14 Feb

BRIEF-HBM Holdings Sees Profit Within Range Of RMB7.3 Mln To RMB22 Mln For Year

Reuters
·
14 Feb

Harbour Biomed Announces Business Progress and Update

THOMSON REUTERS
·
14 Feb

Press Release: Harbour BioMed Announces Business Progress and Update

Dow Jones
·
14 Feb

Hbm Holdings - Expected Result Due to Growth of Its Unique Business Model, Others

THOMSON REUTERS
·
14 Feb

Hbm Holdings Sees Profit Within Range of RMB7.3 Mln to RMB22 Mln for Year

THOMSON REUTERS
·
14 Feb

HBM Buys Back HK$10 Million Shares In One Day; Looks to Form Strategic Partnerships; Shares Rise 15%

MT Newswires Live
·
10 Feb

China Greenlights HBM's Investigational New Drug for COPD

MT Newswires Live
·
05 Feb

Stock Track | HBM Holdings-B Soars 5.66% on Regulatory Clearance for COPD Drug Candidate

Stock Track
·
05 Feb